FDA Approves MED-EL USA’s Cochlear Implants for Single-Sided Deafness and Asymmetric Hearing Loss

July 23, 2019

The U.S. Food and Drug Administration (FDA) has approved MED-EL USA's cochlear implant (CI) system for single-sided deafness (SSD) and asymmetric hearing loss (AHL) [PDF]. This is the first and only time that cochlear implants have been approved for these indications in the United States. People with SSD and AHL experience difficulties hearing in certain listening situations such as noisy environments, and these difficulties have a negative impact on communication and social interaction. The FDA approval will benefit people who have struggled with single-sided deafness or asymmetric hearing loss who do not benefit from traditional amplification. 

Questions?

Please contact ASHA Audiology Practices at audiology@asha.org


ASHA Corporate Partners